Atai stock forecast.

ATAI - ATAI Life Sciences NV Stock quote - CNNMoney.com Markets Tech Media Success Video ATAI Life Sciences NV (NASDAQ:ATAI) 1.07 Delayed Data As of 3:58pm ET -0.055 / -4.91% Today’s...

Atai stock forecast. Things To Know About Atai stock forecast.

Sep 9, 2022 · Presently, ATAI is trading below its 20W EMA, which is an extremely serious red flag. In fact, ATAI only closed above its 20W EMA once, back in late 2021. It’s just that simple to determine if the stock is or was ever a buy. Quick answer – NO! In 2020 and 2021, ATAI spent almost $60M total on R&D. 43.55. -2.16%. 5.29M. Find the latest ATAI Life Sciences BV (ATAI) stock forecast, 12-month price target, predictions and analyst recommendations.WebAs of the end of March 2023, the ETF’s portfolio worth fell to $7.4 billion, as Cathie Wood started to sell stocks last year. According to a Bloomberg report, because of selling stocks at a loss ...NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more.Find the latest Samsara Inc. (IOT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...

ATAI identifies promising mental health technologies or drugs and then acquires a stock interest, providing technical and financial support to hasten the time to market.

Shares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...The Plug Power stock price fell by -2.38% on the last day (Wednesday, 22nd Nov 2023) from $3.57 to $3.48. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 5.97% from a day low at $3.44 to a day high of $3.64. The price has fallen in 8 of the last 10 days and is down by -42.19% for this period.

Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Down -34.59% in 4 Weeks, Here's Why You Should You Buy the Dip in atai Life Sciences N.V. (ATAI) Zacks - Tue Jan 31, 8:35AM CST . atai Life Sciences N.V. (ATAI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings...13. 1. 2023. ... atai Life Sciences Founder Christian Angermayer explains that all will ... Stock Market Sectors You Like 32:39 - 33:42 Optimism For Industry ...Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Real Time Quote from BATS) $1.10 USD 0.00 (0.00%) Updated Nov 27, 2023 10:58 AM ET...

Business, Economics, and Finance. GameStop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla. Crypto

These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...

Find the latest Global Partners LP (GLP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93.Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...

Atai Life Sciences Announces Results from the Phase 1 Iv-To-Subcutaneous Bridging Study of Pcn-101 (R-Ketamine) Aug. 08: CI Atai Life Sciences N.V., Atai Life Sciences AG Enters into the Second Amendment to Loan and Security Agreement with the Several Banks May. 31: CINov 4, 2023 · As such, ATAI has been trading -1490.91% off suggested target high and -286.36% from its likely low. ATAI Life Sciences N.V. (ATAI) estimates and forecasts. Looking at statistics comparing ATAI Life Sciences N.V. share performance against respective industry, we note that the company has outperformed competitors. Stock Price Forecast. The 12 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 21.00, with a high estimate of 50.00 and a low estimate of 6.60. The median estimate represents a +650.00% increase from the last price of 2.80. Analyst Recommendations.ATAI Stock. USD 1.87 0.04 2.09%. ATAI Life Sciences stock price prediction is an act of determining the future value of ATAI Life shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of ATAI Life's future price could yield a significant profit.Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …Find real-time CRM - Salesforce Inc stock quotes, company profile, news and forecasts from CNN Business.The average Compass stock price prediction forecasts a potential upside of 35.39% from the current COMP share price of $2.43. What is COMP's forecast return on equity ...

Nov 18, 2023 · ATAI Life Sciences N.V. stock price forecast for further price development down to -32.20% (time horizon: 1 day) and price target of 1.11 USD. Short-term (time horizon: 2 weeks) ATAI Life Sciences N.V. share price prediction for 2024-01-12 with daily closed price projections Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.

ATAI Stock Price | ATAI Life Sciences N.V. Stock Quote (U.S ...ATAI Life Sciences N.V. (ATAI) stock forecast and price target. Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends …WebATAI Life Sciences NV. $1.12. ATAI 7.69% ; Enveric Biosciences Inc. $1.68. ENVB 13.51% ; Compass Pathways PLC. $6.10. CMPS 2.01% ; ehave Inc. $0.0017. EHVVF 0.00%.ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.Atai’s pipeline features five programs in clinical testing. The company’s lead candidate, RL-007, is being evaluated in a phase 2 clinical study as a potential treatment for schizophrenia.The average Bit Digital stock price prediction forecasts a potential upside of 55.04% from the current BTBT share price of $2.58. What is BTBT's forecast return on equity (ROE) for 2023-2024? (NASDAQ: BTBT) forecast ROE is N/A, which is considered weak.Company profile for ATAI Life Sciences N.V. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ATAI description & address.ATAI Stock Price | ATAI Life Sciences N.V. Stock Quote (U.S ... Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00.Atai Life Sciences N.V. (ATAI) Stock Price, Quote & News - Stock Analysis 1.12 -0.02 (-2.19%) Nov 29, 2023, 10:07 AM EST - Market Overview Financials Statistics …Web

These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...

What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Delayed Data from NSDQ) $1.12 USD +0.08 (7.69%) Updated …Web

Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.Mind Medicine (MNMD) is a biotech company that develops psychedelic-inspired therapies for mental health disorders. Find out how analysts rate the stock and what are its growth prospects on TipRanks.com. You can also access the latest earnings reports, forecasts, and price movements of MNMD on the same platform.---Don't miss this opportunity to …Find real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.Atai Life Sciences saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,630,000 shares, an increase of 20.6% from the previous total of 4,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ...Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. ATAI Life Sciences NV Follow Share $1.11 Nov 22, 2:08:38 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Cybin Inc $0.46 CYBN2.61% Compass Pathways PLC $6.00 CMPS2.92% Mind Medicine... The highest rated platform for investors in the world! TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. TipRanks stock market research and analysis, lets you see the track record and measured performance of any analyst or blogger, so you know who to trust!ATAI Stock Price | ATAI Life Sciences N.V. Stock Quote (U.S ... Next reporting date. February 26, 2024. EPS forecast (this quarter) $0.34. Annual revenue (last year) $960.5M. Annual profit (last year) $40.4M. Net profit margin.STRO Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $13.40 with a high forecast of $17.00 and a low forecast of $10.00. The average price target represents a 396.30% change from the last price of $2.70.Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...

Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00. Detailed statistics for Atai Life Sciences N.V. (ATAI) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The ...According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October.Instagram:https://instagram. health and dental insurance arizonapxys stockdental insurance that covers dentureslattice semiconductor stock Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ... See Atai Life Sciences N.V. (ATAI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. list of healthcare reitsopy market Dec 1, 2023 · Based on short-term price targets offered by four analysts, the average price target for atai Life Sciences N.V. comes to $13.00. The forecasts range from a low of $6.00 to a high of $20.00. The ... 111.91%. Get the latest ATAI Life Sciences NV (ATAI) real-time quote, historical performance, charts, and other financial information to help you make more informed …Web forex canada Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ...See Atai Life Sciences N.V. (ATAI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.